Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
NCT06394570
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Bladder Cancer
Interventions
DRUG:
Enfortumab vedotin
Sponsor
University of Texas Southwestern Medical Center
Collaborators
[object Object]